| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC2130 |
| Trial ID | NCT03994913 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CT032 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma |
| Year | 2019 |
| Country | China |
| Company sponsor | CARsgen Therapeutics Co., Ltd. |
| Other ID(s) | CT032-NHL-01 |
| Cohort 1 | |||||||||||
|
|||||||||||